bioRxiv · 10.1101/2025.07.09.663881
Hypoxia-Induced Metabolic Reprogramming and Markings of Cell Fate in Concentric Arterial Hypertrophy
Abstract
Chronic inhibition of the renin-angiotensin system (RAS), while widely used to treat hypertension, can lead to an underrecognized form of vascular disease marked by concentric arteriolar and arterial hypertrophy (CAAH). Here, using two lineage-traced mouse models of genetic renin deletion and sustained RAS blockade, we uncover a pathogenic cascade initiated by renin-lineage cell fate reprogramming. Loss of endocrine identity and transformation of smooth muscle cells drives a shift toward a fibrotic, inflammatory, and secretory phenotype that remodels the extracellular matrix and promotes vascular thickening and luminal narrowing. Integrated transcriptomic, proteomic, and metabolomic profiling revealed a hypoxia-linked metabolic switch--characterized by succinate accumulation and NAD+ depletion--coupled to Hif activation and disease progression. We identify Cdh13 and collagens (including Col1a1 and Col12a1) as early urinary biomarkers and define a 10-gene molecular signature of CAAH with potential clinical application. These findings establish renin-lineage cell plasticity and metabolic dysfunction as central drivers of CAAH and nominate candidate biomarkers for early detection and therapeutic targeting in RAS-inhibited patients.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Ferreira de Almeida, L., Smith, J. P., Yamaguchi, M., Medrano, S., Martini, A., Matsuoka, D., Juskiewicz, Z. J., Isakson, B. E., Yamaguchi, H., Trevisan-Silva, D., Wagamon, T., Sequeira-Lopez, M. L. S., Gomez, R. A.. 2025-07-14. Hypoxia-Induced Metabolic Reprogramming and Markings of Cell Fate in Concentric Arterial Hypertrophy. https://doi.org/10.1101/2025.07.09.663881
Cite the original work for its findings. Save a collection to share your selection of sources.